Business & Regulation

How pharma can support patients with initial onboarding and ongoing adherence to therapeutic treatments.

Steve Bates gives us the inside scoop on the UK’s Vaccine Taskforce.

History was made this past month as China's National Medical Products Administration approved the country's first CAR T-cell therapy: Yescarta.

How is AI shaping the future of pharma?

How is the OTC industry rising to pharma's biggest challenges?

The lack of female representation in clinical trials impairs the very foundation that the development of safe and effective medicines is built upon.

Efficient data management is critical to meet the demand for fast drug development – especially in light of COVID-19

Experts from the BIA got together to discuss how the UK’s biotechnology industry can plug the UK’s worrying skills gap.

Are there learnings from the COVID-19 pandemic that could be applied to the development and commercialization of advanced therapies?

How can advocacy groups help improve the clinical trials landscape?